Product Liability Archive » May, 2012

Product Liability - May, 2012

241 articles

• Sanction Could Prove Fatal To Toyota In Acceleration MDL
• Costco, Diamond Pet Foods Sued Over Salmonella Outbreak
• 9th Circ. Won't Review Occidental's Peruvian Pollution Case
• Chevron CEO Rebuked For Handling Of $18B Ecuador Case
• Zurich Still On Hook For Defense Costs In Asbestos Suits
• Feds Shutter NYC, Philly Discount Bus Network
• Causation: The Hole In Fracking Contamination Suits
• FDA Says Corn Syrup Can't Be Called 'Sugar'
• Ecuadoreans Confront Chevron Over $18B Oil Spill Judgment
• Dole Likely Escapes Colombian Banana Death-Squad Suit
• House Handily Approves Sprawling FDA Reform Bill
• NC Lawmakers Propose Ban On BPA In Children's Toys
• Pfizer Off Hook In Prempro Breast Cancer Case
• House Dem Urges DOJ To Probe BP's Statements To Congress
• Insurer Says Citgo Not Entitled To Pollution Defense Coverage
• Ex-FDA Counsel Joins Crowell & Moring
• Minn. High Court Stubs Out Philip Morris 'Lights' Row
• Goodyear Wants Perkins Coie Ousted From Faulty Hose Suit
• FDA May Shut Down Spice Co. Over Salmonella, Insects
• Tried And True Summary Judgment In Failure-To-Warn Cases
• FDA Warns J&J It Can't Slip Away From K-Y Complaints
• FDA Downplays Fukushima-Tainted Tuna Found In Calif.
• NJ Atty Hits Ex-Firm With Whistleblower Suit Over Runner Use
• NRC Soft on Risk Assessment, GAO Says
• EPA Steps Up Regulation Of Products Containing Mercury
• Investors Urge Chevron CEO To Settle $18B Rain Forest Suit
• US Backs Reversal Of $1B Plutonium Ruling Against Dow
• FEMA Trailer MDL Plaintiffs Strike Broad Settlement
• Regulators Poised To Fine PG&E Over Pipeline Violations
• Upholding Ill. Manufacturers' Limited Post-Sale Duties
• Supreme Court Declines Hearing In Bridge Collapse Suit
• Dewey & LeBoeuf Files For Bankruptcy
• FDA Appeals Death Penalty Drug Ban To DC Circ.
• Sen. Seeks Keen Eye On KBR's Use Of Indemnity In Iraq Suits
• Calif.'s Proposed Wildfire Liability Cap Sparks Criticism
• NY Grand Jury Pins Pain Pill Abuse On Drugmakers, Doctors
• Human Genome Denies Hiding Suicide Risks In Lupus Drug Case
• Bracewell Gets Litigation Star From Patton Boggs
• Syngenta To Pay $105M To End Herbicide Pollution Claims
• 2nd Circ. Keeps Alive UN Wall Collapse Suit Against Namibia
• McGuireWoods Adds Toxic Tort Pro From Bowman And Brooke
• Judge Pares Chevron's RICO Suit Over $18B Pollution Ruling
• Tightening FDA Nanotech Regs On Food, Cosmetics
• Europe Clears Roche Cancer Drug After Contamination Report
• Study Links Calcium Products To Higher Heart Risks
• Hennessy Stems Tide Of Calif. Asbestos Losses
• Lab Tied To Eye Infections Halts Sterile Drug Production
• Ford, Honeywell Win Big In Pa. Asbestos Test Case
• Massey Case On Brink Of Trial After Failed Mediation
• Offshore Driller Noble Makes Peace In $50M Wire Defect Suit
• GM Recalls 4,300 Chevy Malibus Over Airbag Problem
• The TSCA, Lead And The Division Of The Hazardous Bullet
• Paramount Pays $19M To End 'Transformers 3' Head Injury Suit
• FDA Panel Won't Back J&J's Xarelto For ACS Patients
• NJ Panel Advances Bill Speeding Class Cert. Appeals
• Court Must Decide If Sept. 11 Was 'Act Of War': 2nd Circ.
• Dexatrim Maker Says Suit Doesn't Show Harm From Carcinogen
• CPSC To Require Audits Of Children's Product Testing Groups
• Exxon Tells 2nd Circ. $105M MTBE Verdict Premature
• Groups Say $5.6M Award Against Kia Violates Due Process
• Upholding CWA Negligence Standard In The 5th Circuit
• Stryker Not Liable For Man's Cartilage Damage, 6th Circ. Says
• EU Adopts Plan To Strengthen Consumer Protection Rules
• Employers Only Liable For Workers' Asbestos Ills: Calif. Court
• DOD Contractors Under Fire In Counterfeit Parts Report
• Judge Won't Reconsider CEO Liability For J&J Recalls
• Md. Bans Use Of Pfizer Affiliate's Chicken Feed Additive
• An Unprecedented Settlement For FDCA Violation
• FDA Seizes Drugmaker's Unapproved Topical Scar Treatment
• Senators Slather Scorn On FDA After Sunscreen Label Delay
• Best Practices For Corporate Social Responsibility
• Prostate Cancer Test Not Worth Risk, Advisory Panel Says
• GAO Urges CPSC To Expand Role In Setting Industry Standards
• Pfizer Hasn't Proved Rare-Disease Drug Works, FDA Staff Says
• Calif. Senate Rejects CPUC Transparency Bill
• 7th Circ. Rejects Securities Suit Over Zimmer Hip Implant
• FDA Reviewer Backs J&J's Xarelto For Heart Condition
• Driverless Car Safety Bill Zooms Out Of Calif. Senate
• 8 Williams Montgomery & John Attys Form New Chicago Firm
• Bristol, Sanofi Say Plavix Marketing Suit Isn't Supported
• 1st Circ. Says Insurer Must Cover Oxford Plane Repair Suit
• Deepwater Responders Argue Immunity To Negligence Claims
• Chrysler Recalls 67K Jeep Wranglers Over Fire Risk
• Finding Jurisdiction Over Foreign Defendants — Online
• OSHA Steps Up Efforts To Revamp Whistleblower Program
• Insurer, Manufacturer Trust End $5M Asbestos Coverage Row
• 3rd. Circ. Revives Owens Corning Shingles Class Action
• Developer Had No Duty To Reveal Bomb Site, 11th Circ. Rules
• FDA Says Korean Shellfish Risk Contact With Human Waste
• Struggling J&J Unit Recalls Immodium Over Package Tears
• 'Spider-Man' Producers Must Give Docs To Hurt Stuntman
• A Duty To Warn — For The Other Manufacturer's Product?
• Gas Co. Equitable Balks At Driller's Indemnity Claim
• Judge Keeps Faulty Deck Class Action In Federal Court
• Class Cert. Denied In Toxic Water Suit Against Ill. Town
• GM Speeds Out Of OnStar Analog MDL
• Boeing, Honeywell Sued Over Deadly 2010 Plane Crash
• Bayer Pays $15M To Soothe Consumers In Aspirin MDL
• DOL Ruling To Embolden Consumer Safety Whistleblowers
• FDA To Look At Study Linking Antibiotic To Cardiac Death
• Firm Wants Travelers Sanctioned Over Bid To Replace Counsel
• Acura Recalls Nearly 57K TL Sedans Over Leak, Fire Risk
• Evolution Of Coverage For Construction Defect Claims
• Feds Shut Down Off-Label Bone Graft Probe, Medtronic Says
• Aon Accused Of Subpar Coverage After Fatal Plant Blast
• Travelers Must Cough Up Docs In Mine Pollution Coverage Row
• Texas Refiner Loses Appeal Of $5M Verdict For Hurt Worker
• Senate's New FDA User Fee Bill Adds Funds For Rare Diseases
• 3rd Circ. Scraps 2 Schering Off-Label Marketing Actions
• Specialty Products' Asbestos Creditors Float Ch. 11 Plan
• Calif. Homeowner Targets Class Over Plumbing MDL Talks
• FSMA's Potential Impact, Part 1: Force Majeure Clauses
• Tishman Seeks 2nd Circ. Knockout Of 7 WTC Liability Suit
• Pentagon Restricts F-22 Flights Amid Safety Concerns
• 4th Circ. Affirms Black Lung Benefits For Coal Miner's Widow
• 5th Circ. Upholds Wastewater Cos.' Convictions In CWA Case
• Panel OKs Calif. Bill For CPUC To Review US Safety Guidance
• Chinese Drywall Developer Makes $5M Deal With Homeowners
• Golden Eagle Escapes $29M Wrongful Death Coverage Suit
• Missing Link: Food, Drug Safety In Foreign Supply Chain
• NHTSA Scopes Hyundai Elantra's Air Bag System
• Bret Michaels, CBS Resolve Tony Awards Injury Suit
• Judge Thins Malpractice Suit Over Child's Motrin Case Verdict
• NRDC Pushes To Reopen FDA Suit Over Soap Chemicals
• 41 AGs Back Bill Allowing Suits Over Generic-Drug Warnings
• Boeing Settles For $40M In Santa Monica Groundwater Fight
• Judge Trims Chevron's RICO Suit Against Ecuadoreans' Atty
• FDA Urges Caution For Users Of Novartis' MS Drug
• FDA Delays Deadline For Stricter Sunscreen Labeling Rules
• Takeda Calls FCA Suit Over Unsafe Drug Interactions Baseless
• Addressing Corporate Liability Under The TVPA, ATS
• Hospira Recalls Overfilled Hydromorphone Injections
• Travelers' Delay Dooms Bid To Control Centex Defense
• Lone Pine Strategy Yields Drillers' Win In Fracking Suit
• Biotechs Push FDA For Clear-Cut Biosimilar Labeling Rules
• Force-Fed Foie Gras Violates Law, Threatens Health: Suit
• Ikea Faces $1M Faulty Candle Suit In Fed. Court
• FDA Quizzed On Antibiotic Use In Corn-Based Animal Feed
• Insurers Deny They Owe Costs For Mining Co.'s Asbestos Feuds
• New House Bill Aimed At Detecting Medical Device Risks
• Canadian Ruling Puts Seroquel Suits In Limbo
• South Korea To Continue Importing US Beef After Review
• GE Must Aid Blowout Preventer Defense, Gas Co. Says
• Reed Smith Snags Product Liability Guru From Dechert
• Document Review Considerations
• Shanghai GM Launches Recall Of 47,000 Chevrolet Aveos
• Apple Gets IPhone Signal Strength Suit Shut Down
• FDA Bone Drug Study Offers New Pathway For Plaintiffs
• Novartis, Lilly Rebut Indian Lawmakers' Collusion Claims
• FDA Panel Backs Approval Of Drug For HIV Prevention
• Sony, Activision Win Suit Over Console-Scorching Games
• Ford Recalls 32K More Windstars Over Frame, Axle Cracks
• Con Ed Hit With $1M Suit Over Fire At Labaton Offices
• Panel Pushes For Asbestos Trusts To Publish Claimants' Info
• FDA Targets Experimental Multiple Sclerosis Treatment
• Where Lies The Liability? Up To Plaintiffs To Prove
• FDA Warns Against Long-Term Use Of Osteoporosis Drugs
• Where Rubber Hits Road: Examples Of Alternative Fees
• $17M Deal Reached in Suit Over Deadly Duck Boat Crash
• Lap-Band Marketer, Clinics Can't Push Patients Into Arbitration
• Insurers Sue Car Parts Maker Hennessy Over Asbestos Claims
• BNSF Pays $36M To Settle Mont. Rail Yard Pollution Suit
• Exxon Unit Told To Probe La. Pipeline Oil Spill
• Suits Against Reglan Generics Can't Skirt Mensing: NJ Court
• Westfield Sues GE Over Coverage For Hog Farm Fire
• FDA Advisory Panel Backs Pfizer Arthritis Drug
• Calif. Strikes $2M Deal Over San Francisco Bay Oil Spill
• La. Recalls Oysters After Norovirus Outbreak
• FDA Wants Child-Size Radiation Doses From Medical Imagers
• A Layered Approach To Protecting CPSIA Whistleblowers
• TransCanada Says Contractor Botched Welder Oversight
• Hawaii Fed. Court To Hear Pollution Suit Against DuPont
• RAM Faces Fines For Counterfeit, Contaminated Mesh
• Arena Faces New FDA Worries Over Weight-Loss Drug
• Feds Want Accurate Pipeline Records After Deadly Explosion
• Insurers Rip Pittsburgh Corning's Ch. 11 Asbestos Trust
• FDA Panel Votes Against Approving Regeneron's Gout Drug
• FDA Says Celgene's Revlimid Tied To Higher Cancer Risks
• House Panel OKs FDA User Fees Bill Despite Sticking Points
• Mission Impossible: Impossibility Preemption Post-Levine
• Top Female Trial Attorney: Reed Smith's Barbara Binis
• L'Oreal Says Hair Serum Plaintiffs Lack Standing To Sue
• Auto Machinery Maker Loses Another Calif. Asbestos Ruling
• Exelon Ducks Claim That Nuke Plant Caused Girl's Cancer
• Reed Smith Snags Product Liability Pro From Dechert
• NY, Fla. Claims Trimmed In Toyota Acceleration MDL
• Shook Hardy Lures Product Liability Pro From Dechert
• Chelsea Hotel Landlord, Tenants Reach Repair Deal
• NFL Player's Son Pushes For Remand Of Key Concussion Suit
• Diamond Expands Recall Of Dog Food Linked To Salmonella
• Abbott To Pay $1.6B To Settle Depakote Allegations
• Gruber Hurst Snags Locke Lord Commercial Litigation Pro
• Implications — And Complications — Of Undoing Mensing
• Thompson Coburn Lures Product Liability Pro From Lewis Rice
• Dismissing FCA Cases Over Relators' Objections
• Pfizer Arthritis Drug Has Safety Risks, FDA Report Says
• Diver Sues BP, Others Over Deepwater Cleanup Injuries
• Interior's Bid To Boost Fracking Disclosures Draws Fire
• Hangover Reliever Can't Swallow Opponent's Discovery Delay
• Continental Asks High Court To Mull Arbitration In Thorpe Case
• FDA Panel To Find If Regeneron Gout Drug's Risks Too High
• Calif. Lawmaker Asks USDA To Investigate 'Meat Glue'
• Salmonella Outbreak In 9 States Tied To Dog Food
• Law360 Names Top Female Trial Attorneys
• Alexza's Manufacturing Issues Delay FDA Approval Of Adasuve
• What Triggers First-Party Coverage: Facts, Not Fear
• Toyota Wins Partial Dismissal Of Prius Headlight Suit
• FAA Aims To Fine Alaska Airlines, Horizon Air Over Safety
• Genzyme Irons Out FCA Suits Over Surgery Product Marketing
• Deepwater Horizon Spill Trial Pushed Back To 2013
• Groups Fear Obama Order Sends Excessive Power Overseas
• Ariz. Lawmakers Pass Bill To Restrict Punitive Damages
• K&L Bolsters Commercial Disputes Group With SC Partner
• 6th Circ. Upholds Class In Whirlpool Moldy Washer Suit
• A Defendant Wronged: When Jury Instructions Go Awry
• GAO Finds Gaps In DOD Policies On Base Contamination
• Cheese Distributors Deny Charges Over Contaminated Product
• Predictive Coding — Putting The Cart Before The Horse
• BP's $7.8B Deepwater Spill Deal Scores Initial OK
• Calif. Judge Trims Insurer From Arrow Cleanup Coverage Suit
• $5M Punitive Award Reversed In Philip Morris Engle Suit
• 1st Circ. Affirms $26M Award In Sulindac Injury Suit
• SmithAmundsen Snags 2 New Partners From Gallop, Lashly
• FDA Warnings Spawn Slew Of Exercise Supplement Suits
• GMO Labeling Initiative Ballot-Ready, Calif. Group Says
• USDA Takes Steps To Speed Up E. Coli Tracking
• The Uncertain Fate Of Learned Intermediary Doctrine
• Calif. Tobacco Tax Proposal Draws Fire From Lawmakers
• Ala. Calls For Deepwater Trial By Year's End
• Calif. Court Revives 5 Hennessy Asbestos Suits
• Judge Sets Up $21M Fund For Welding Fumes MDL Plaintiffs
• Big Biz Hails Obama's Order To Align International Regs
• FDA Urged To Require Ongoing Safety Checks For Risky Drugs
• 3rd Circ. Lets Federal-Mogul Move Policies To Asbestos Trust
• Citing Smith V. Bayer, 7th Circ. Allows Sears Dryer Suits
• St. Jude's Device Liability May Not End With Recalls: Report
• FDA Revised Benefit-Risk Criteria — Embracing Innovation
• 9th Circ. Firsts: Equitable Mootness And Arbitration
• OneBeacon Off Hook For $7M Lead Paint Lobbying Tab
• 6th Circ. Won't Overturn Fen-Phen Attys' Convictions
• Chattem Concealed Carcinogen In Dexatrim, Suit Says